Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A See

Showing results (11-20 of 251) with videos related to

Pageof 26
Sort By:
Urologic Oncology|June 26, 2013
Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28]William A See
Journal of the National Cancer Institute|September 10, 1998
Re: Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell linesW A See
The Journal of Urology|August 25, 2010
Re: Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes: W. T. Lowrance, E. B. Elkin, L. M. Jacks, D. S. Yee, T. L. Jang, V. P. Laudone, B. D. Guillonneau, P. T. Scardino and J. A. Eastham J Urol 2010; 183: 1366-1372William A See
Urology|August 5, 2000
Continuous antegrade infusion of adriamycin as adjuvant therapy for upper tract urothelial malignanciesW A See
The Journal of Urology|December 1, 1994
Commentary on growth factors: the bread-and-butter cytokines of urologyW A See
European Urology|December 3, 2013
Re: use of advanced treatment technologies among men at low risk of dying from prostate cancerWilliam A See
The Journal of Urology|February 1, 1996
Radical cystectomy--cornerstone or millstone?W A See
Urologic Oncology|August 6, 2013
A manpower calculus: the implications of SUO fellowship expansion on oncologic surgeon case volumesWilliam A See
Urologic Oncology|December 10, 2014
Commentary on "Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective?" Wong KA, Zisengwe G, Athanasiou T, O'Brien T, Thomas K, The Urology Centre, Guys and St. Thomas' NHS Foundation Trust.: BJU Int 2013; 112(5):561-7. doi:10.1111/bju.12216. [Epub 2013 Jul 2]William A See
Urology|September 1, 1995
Council-tip catheter facilitates vesicourethral anastomotic suture placementW A See
Pageof 26

Showing results (11-20 of 251) with videos related to

Sort By:
Pageof 26
Urologic Oncology|June 26, 2013
Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28]William A See
Journal of the National Cancer Institute|September 10, 1998
Re: Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell linesW A See
The Journal of Urology|August 25, 2010
Re: Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes: W. T. Lowrance, E. B. Elkin, L. M. Jacks, D. S. Yee, T. L. Jang, V. P. Laudone, B. D. Guillonneau, P. T. Scardino and J. A. Eastham J Urol 2010; 183: 1366-1372William A See
Urology|August 5, 2000
Continuous antegrade infusion of adriamycin as adjuvant therapy for upper tract urothelial malignanciesW A See
The Journal of Urology|December 1, 1994
Commentary on growth factors: the bread-and-butter cytokines of urologyW A See
European Urology|December 3, 2013
Re: use of advanced treatment technologies among men at low risk of dying from prostate cancerWilliam A See
The Journal of Urology|February 1, 1996
Radical cystectomy--cornerstone or millstone?W A See
Urologic Oncology|August 6, 2013
A manpower calculus: the implications of SUO fellowship expansion on oncologic surgeon case volumesWilliam A See
Urologic Oncology|December 10, 2014
Commentary on "Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective?" Wong KA, Zisengwe G, Athanasiou T, O'Brien T, Thomas K, The Urology Centre, Guys and St. Thomas' NHS Foundation Trust.: BJU Int 2013; 112(5):561-7. doi:10.1111/bju.12216. [Epub 2013 Jul 2]William A See
Urology|September 1, 1995
Council-tip catheter facilitates vesicourethral anastomotic suture placementW A See
Pageof 26